Loading
Macrolide·Infectious Diseases - Macrolides
Penicillin-allergic patients with susceptible infections
Max Dose
4 g/day
Half-life
1.5 h
GI Upset
SEVERE
Prokinetic
OFF-LABEL
Overview
The original macrolide antibiotic. Due to its short half-life, severe GI toxicity, and massive drug interactions, it is largely obsolete as an antibiotic. Now heavily utilized as an IV prokinetic to force gastric emptying.
Maximum Dose
Max 4 g/day.
Clinical Focus
Like Clarithromycin, it is a potent CYP3A4 inhibitor. Causes agonizing stomach cramps by massively stimulating gut motilin receptors.
Bottom Line
Erythromycin is a macrolide useful for respiratory infections and as a prokinetic agent, but causes significant GI disturbance and has extensive CYP3A4 drug interactions.
Brand Names
Eryc, EES
Oral Routes
Capsules/Tablets (250 mg, 400 mg).
Parenteral
Vials (1 g powder) for IV infusion.
Prescribing & PBS
Unrestricted General Benefit (S4).
Primary
Penicillin-allergic patients with susceptible infections.
Off-Label
Gastroparesis, clearing blood from the stomach prior to an urgent endoscopy for a GI bleed.
Clinical Place
Almost entirely replaced by Azithromycin and Clarithromycin for infections. Survives in hospitals entirely as a GI motility agent.